Cannabis Law Report

SEPTEMBER 14, 2021

WHEREAS, for those individuals who were formerly incarcerated, a recent analysis by the Prison Policy Initiative shows that more than 27 percent are unemployed, which is a higher rate than the overall unemployment rate during the Great Depression; and.

Policy 98

Policy Research and Development Access Cannabis 98

Cannabis Law Report

MAY 26, 2022

The objective of the current study was to assess the ease of access to marijuana by underage patrons at recreational marijuana outlets in California, where recreational marijuana was legalized in 2016. 2001, Toomey et al., 2001, Toomey et al., 2001, Voas et al., Marijuana use at any level can impair driving performance.

Dispensary 52

Dispensary Research and Development Safety Recreational 52

SpeedWeed

MAY 20, 2021

Today, John Fetterman is a champion of progressive policy reforms he considers common sense. is in the midst of a Senate run where he isn’t holding back on the policies he feels America needs to embrace. . Fetterman endeavors to advance pot-policy with his actions and his deliberate choice of words.

Legalization 52

Legalization Policy Access Topical 52

Sensi Seeds

JANUARY 4, 2019

Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). It allows patients to have access to medicinal cannabis without danger of being criminalized. Context of the Medicinal Cannabis Situation.

Medicine 75

Medicine Research and Development Patients Programs 75

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Refractory paediatric epilepsy.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

APRIL 8, 2022

MAPS hired Sylvia Thyssen as our first employee , celebrated the 50th anniversary of LSD , outlined perspectives on drug policy , and worked toward facilitating a pilot study for medical marijuana. Rick Doblin, Ph.D., and Michael Mithoefer, M.D., met for the first time and decided to work on MDMA/PTSD research in the U.S.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

FEBRUARY 22, 2019

InPlanta is the technical partner of the Corporation that has granted a License Agreement to ACC entitling the Company to access the hemp-oriented horticultural, scientific, genealogical and related advice produced by InPlanta for application in the general Asian market. Kingma has been self-employed since 2001. Read more: [link].

Hemp 40

Hemp Research and Development Hybrid Strains 40